Physician profile
Michael Cohen
NPI 1396942231
$13,807.31
in general payments reported to CMS, 2019-2025
39 companies · $1,712 in 2025
The $1,712 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,417 · 2020: $401 · 2021: $945 · 2022: $5,414 · 2023: $2,004 · 2024: $1,915 · 2025: $1,712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,615 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,614.98 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,673.79 | 2019-2025 | Aveir, Gallant, Mitraclip |
| Penumbra, INC. | $3,133.28 | 2021-2023 | Indigo System |
| Abiomed | $2,852.40 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $455.55 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $403.65 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $319.34 | 2023-2025 | General - Tachy, Watchman Flx |
| Cardiovascular Systems INC. | $283.55 | 2020-2021 | |
| Tepha INC | $250.84 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $222.73 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $202.03 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $172.67 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cvrx, INC. | $168.02 | 2025 | Barostim Neo System |
| Amgen INC. | $165.07 | 2019-2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $160.31 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $146.43 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $127.08 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbvie INC. | $118.66 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $117.73 | 2019 | |
| Bsn Medical INC | $97.99 | 2023 | |
| Medtronic, INC. | $94.97 | 2022 | |
| Lantheus Medical Imaging, INC. | $93.73 | 2024 | |
| Heartflow, INC. | $58.79 | 2023-2025 | Ffrct |
| Astrazeneca Pharmaceuticals Lp | $55.90 | 2019-2024 | Lokelma, Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $52.41 | 2021-2024 | Xarelto |
| Pfizer INC. | $49.30 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $44.02 | 2021-2025 | Camzyos |
| W. L. Gore & Associates, INC. | $41.48 | 2022 | |
| Medicomp INC | $37.88 | 2024 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $28.50 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $24.68 | 2024 | Optimizer |
| Cleerly, INC. | $24.37 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Chiesi USA, INC. | $23.48 | 2025 | Juxtapid |
| Kiniksa Pharmaceuticals International, Plc | $17.00 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, Ltd. | $16.43 | 2023 | Arcalyst |
| Preventice Services, LLC | $15.44 | 2019 | |
| Ucb, INC. | $14.93 | 2019 | |
| Esperion Therapeutics, INC. | $14.72 | 2023 | Nexletol |
| Eisai INC. | $14.45 | 2023 | |
| Avanir Pharmaceuticals, INC. | $13.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.